Patent details

Basic Information

Publication number:

EP1856041

PCT Application Number:

PCT/GB/2006/000770

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP067099937

PCT Publication Number:

WO/2006/092617

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CRYSTALLISATION AND PURIFICATION OF GLYCOPYRRONIUM BROMIDE

French Title of Invention:

CRISTALLISATION ET PURIFICATION DE BROMURE DE GLYCOPYRRONIUM

German Title of Invention:

KRISTALLISATION UND AUFREINIGUNG VON GLYKOPYRRONIUMBROMID

SPC Number:

Dates

Filing date:

03/03/2006

Grant date:

13/05/2009

EP Publication Date:

13/05/2009

PCT Publication Date:

08/09/2006

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/11/2007

EP B1 Publication Date:

13/05/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

03/03/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/05/2024

 

 

Name:

NXERA PHARMA UK LIMITED

Address:

Granta Park, Great Abingdon, CB21 6DG, Cambridge, Cambridgeshire , United Kingdom (GB)

History of Owners

From:

02/01/2019

To:

21/05/2024

Name:

Heptares Therapeutics Limited

Address:

Granta Park, Great Abington, Cambridge, Cambridgeshire CB21 6DG, United Kingdom (GB)

From:

03/03/2006

To:

02/01/2019

Name:

Sosei R&D Ltd.

Address:

Chesterford Research Park, Little Chesterford Saffron Walden Essex, United Kingdom (GB)

Inventor

1

Name:

SINDEN Kenneth Walter Sosei R & D Ltd.

Address:

United Kingdom (GB)

2

Name:

BAXTER Andrew Douglas Sosei R & D Ltd.

Address:

United Kingdom (GB)

3

Name:

KLEINEBEKEL Stefan, Girindus AG

Address:

Germany (DE)

Priority

Priority Number:

0504463

Priority Date:

03/03/2005

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 207/12;

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2019/02

Publication date:

22/02/2019

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

CO

Bulletin edition number:

2024/07

Publication date:

03/06/2024

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20190000003A

Date Registered:

02/01/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Heptares Therapeutics Limited

Address:

Granta Park, Great Abington, Cambridge, Cambridgeshire CB21 6DG, United Kingdom (GB)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20240000237A

Date Registered:

21/05/2024

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

NXERA PHARMA UK LIMITED

Address:

Granta Park, Great Abingdon, CB21 6DG, Cambridge, Cambridgeshire , United Kingdom (GB)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

17/02/2025

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
02/01/2019	Request For Change	19
22/01/2019	Outgoing Correspondence	1
21/05/2024	Request For Change	1
22/05/2024	Outgoing Correspondence	1